Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma
about
Early detection and personalized treatment in oral cancer: the impact of omics approachesMolecular pathology of cancer: how to communicate with diseaseNext-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach.ON 01910.Na (rigosertib) inhibits PI3K/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines.Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA.
P2860
Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Liquid biopsy monitoring uncov ...... d neck squamous cell carcinoma
@en
Liquid biopsy monitoring uncov ...... neck squamous cell carcinoma.
@nl
type
label
Liquid biopsy monitoring uncov ...... d neck squamous cell carcinoma
@en
Liquid biopsy monitoring uncov ...... neck squamous cell carcinoma.
@nl
prefLabel
Liquid biopsy monitoring uncov ...... d neck squamous cell carcinoma
@en
Liquid biopsy monitoring uncov ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P921
P356
P1433
P1476
Liquid biopsy monitoring uncov ...... d neck squamous cell carcinoma
@en
P2093
Aneta Schieferdecker
Carsten Bokemeyer
Chia-Jung Busch
Friederike Braig
Malte Kriegs
Mascha Binder
Minna Voigtlaender
Rainald Knecht
Simon Laban
Tobias Grob
P2860
P304
42988-42995
P356
10.18632/ONCOTARGET.8943
P407
P577
2016-04-22T00:00:00Z